Myocardial Fibrosis: Assessment, Quantification, Prognostic Signification, and Anti-Fibrosis Targets: A State-of-the-Art Review
Journal of Cardiovascular Development and Disease · 18.05.2025 · 12 (5) · 192
DOI: 10.3390/jcdd12050192 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 18.05.2025. Verfasst von Salvatore Poddi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, University of Verona Medical Center, 37126 Verona, Italy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myocardial fibrosis (MF) is the excessive deposition of extracellular matrix (ECM) from myofibroblasts and is crucial in patients with heart failure (HF). Much work is still needed to fully understand its features and clinical role. This review aims to summarize the state-of-the-art of MF knowledge, focusing on assessment, quantification, predictive value, and future therapies. We performed a literature search about MF studies published between 2014 and 2024, including clinical studies on MF assessment or quantification, the role of MF as a prognostic factor in patients with HF, basic science studies on fibrosis assessment, and the role of the main mechanisms involved in MF. We identified 5161 potentially relevant articles. After excluding non-appropriate ones, we had 186 potentially suitable studies. After full reading and a review of references, 40 articles were included in our review: 8 were about MF assessment, 5 about quantification, and 27 about fibrosis as a prognostic factor. MF is a crucial process in patients with cardiac diseases and leads to HF and arrhythmias. Assessment and quantification have taken great steps forward, but more research is needed to strengthen MF’s role as a prognostic factor in the future. Basic science will play a key role in anti-fibrosis treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, University of Verona Medical Center, 37126 Verona, Italy.
- George Emil Palade University Medical School, 540139 Targu-Mures, Romania.
- Division of Cardiothoracic Surgery, Mater Misericordiae University Hospital, D07 R2WY Dublin, Ireland.
ORCID-Profile: Cynthia L Lefter, Daniele Linardi, Giovanni B Luciani
Zitieren
APA
Poddi, S., Lefter, C. L., Linardi, D., Ardigò, A., Luciani, G. B., & Rungatscher, A. (2025). Myocardial Fibrosis: Assessment, Quantification, Prognostic Signification, and Anti-Fibrosis Targets: A State-of-the-Art Review. Journal of Cardiovascular Development and Disease, 12(5), 192. https://doi.org/10.3390/jcdd12050192
Vancouver
Poddi S, Lefter CL, Linardi D, Ardigò A, Luciani GB, Rungatscher A. Myocardial Fibrosis: Assessment, Quantification, Prognostic Signification, and Anti-Fibrosis Targets: A State-of-the-Art Review. Journal of Cardiovascular Development and Disease. 2025;12(5):192. doi:10.3390/jcdd12050192
BibTeX
@article{Poddi2025,
author = {Poddi, Salvatore and Lefter, Cynthia L and Linardi, Daniele and Ardigò, Andrea and Luciani, Giovanni B and Rungatscher, Alessio},
title = {Myocardial Fibrosis: Assessment, Quantification, Prognostic Signification, and Anti-Fibrosis Targets: A State-of-the-Art Review},
journal = {Journal of Cardiovascular Development and Disease},
year = {2025},
volume = {12},
number = {5},
pages = {192},
doi = {10.3390/jcdd12050192}
}
EUVIMED